| Co-transcriptional DNA and RNA cleavage during type III CRISPR-Cas immunity P Samai, N Pyenson, W Jiang, GW Goldberg, A Hatoum-Aslan, ... Cell 161 (5), 1164-1174, 2015 | 407 | 2015 |
| A synthetic biology framework for programming eukaryotic transcription functions AS Khalil, TK Lu, CJ Bashor, CL Ramirez, NC Pyenson, JK Joung, ... Cell 150 (3), 647-658, 2012 | 366 | 2012 |
| Broad targeting specificity during bacterial type III CRISPR-Cas immunity constrains viral escape NC Pyenson, K Gayvert, A Varble, O Elemento, LA Marraffini Cell host & microbe 22 (3), 343-353. e3, 2017 | 122 | 2017 |
| Creating single-copy genetic circuits JW Lee, A Gyorgy, DE Cameron, N Pyenson, KR Choi, JC Way, PA Silver, ... Molecular cell 63 (2), 329-336, 2016 | 70 | 2016 |
| Type III CRISPR-Cas systems: when DNA cleavage just isn’t enough NC Pyenson, LA Marraffini Current opinion in microbiology 37, 150-154, 2017 | 53 | 2017 |
| Co-evolution within structured bacterial communities results in multiple expansion of CRISPR loci and enhanced immunity NC Pyenson, LA Marraffini Elife 9, e53078, 2020 | 28 | 2020 |
| Expansion of CRISPR loci with multiple memories of infection enables the survival of structured bacterial communities NC Pyenson, LA Marraffini bioRxiv, 747212, 2019 | 1 | 2019 |
| O1‐04‐08: C. elegans models of Alzheimer's disease and Parkinson's disease: Systems biology identifies an interaction between tau and LRRK2 B Wolozin, M Guillily, A Ferree, H Li, N Pyenson, K Smith, S Saha, ... Alzheimer's & Dementia 6, S78-S78, 2010 | | 2010 |
